PMHNP Telehealth | Reviewed July 2026
Telehealth Prescribing for PMHNPs (2026)
Telehealth has become central to psychiatric care, but the rules for prescribing through it, especially for controlled substances, are actively evolving at the federal level. This page explains the landscape and, most importantly, where to verify the current rules before you prescribe.
Read This First
Why This Page Points You Elsewhere
Telehealth prescribing of controlled substances is one of the fastest-moving areas of federal health regulation. The temporary flexibilities that began during the COVID-19 public health emergency have been extended more than once, and a permanent framework is still being developed. Because the rules can change on relatively short notice, this page is deliberately written as a map of the landscape and a set of authoritative places to check, not as a list of rules you can act on directly.
Before you prescribe anything by telehealth, and especially any controlled substance, confirm the current requirements with two primary sources: the U.S. Drug Enforcement Administration (DEA) and your own state board of nursing and state controlled-substance authority. What is accurate on the day this page was reviewed may have changed by the time you read it. Treat the date at the top of this page as a hard boundary on how current this information is.
The Foundation
Non-Controlled vs. Controlled: Two Different Conversations
It helps to separate two very different categories, because they are governed differently.
Non-Controlled Medications
Many psychiatric medications, including a large share of antidepressants and other non-scheduled agents, are not controlled substances. Prescribing these via telehealth is generally more straightforward and is primarily governed by your state’s telehealth and scope-of-practice rules and the standard of care, rather than by the DEA’s controlled-substance framework. State requirements still apply, so verify them.
Controlled Substances
Scheduled medications, including certain stimulants and other controlled agents used in psychiatry, sit under a separate and stricter federal framework tied to the Ryan Haight Act and DEA rules. This is the area that is actively changing, and where you must verify current requirements before prescribing.
The rest of this page focuses on the controlled-substance side, because that is where the uncertainty and the risk concentrate. For non-controlled prescribing, your state board and standard-of-care expectations are the main references.
The Legal Backdrop
The Ryan Haight Act and Why It Matters
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is the federal law that historically shaped controlled-substance prescribing over the internet. In broad terms, and subject to specific exceptions, it established that a practitioner generally needed to conduct at least one in-person medical evaluation of a patient before prescribing a controlled substance to them remotely. This is the baseline that the pandemic-era flexibilities temporarily relaxed, which is why those flexibilities are described as temporary exceptions and why a permanent framework is being worked out.
That context is useful, but it is not a substitute for the current operative rules. The exact scope of the statute, its exceptions, and how it interacts with today’s flexibilities are legal questions. Confirm how they apply to your situation with the DEA and qualified counsel rather than relying on a summary.
Where Things Stand
The Current Landscape (as Reviewed July 2026)
As of this page’s review date, the picture is best summarized this way: the pandemic-era telemedicine flexibilities for prescribing controlled medications have been extended by the DEA and HHS, and work on a permanent framework, including a proposed special registration pathway for telemedicine prescribing, is still in progress. The temporary flexibilities have not simply lapsed, but they also have not been replaced by a settled permanent rule.
We are intentionally not stating a specific expiration date or a firm “you can” or “you cannot” rule for prescribing a given controlled substance by telehealth. Those specifics have changed before and can change again, and publishing them here risks handing you information that is out of date by the time you act on it. What you can rely on is this: there is an active, extended set of flexibilities alongside an evolving permanent framework, and the only trustworthy source for the current status is the DEA and your state authorities on the day you prescribe.
Verify With the DEA
The DEA publishes the current federal rules, extensions, and any permanent framework as it is finalized. Check it directly, and note the effective dates on whatever you find.
Verify With Your State Board
Federal rules are a floor, not the whole picture. Your state board of nursing and state controlled-substance authority set additional requirements that can be stricter. Confirm both.
Re-Verify Over Time
Because a permanent framework is still evolving, treat this as something to re-check periodically, not a one-time confirmation. What is true this quarter may differ next quarter.
Fifty Different Answers
State-by-State Variation Is the Rule, Not the Exception
Even where a federal flexibility exists, your state may impose its own conditions, and states differ significantly. Variation shows up in several places at once.
| Area | What can vary by state |
|---|---|
| Scope of practice | Whether a PMHNP practices independently or under a collaborative or supervisory arrangement, which can affect prescribing authority. |
| Telehealth modality | Whether audio-video is required, and how audio-only encounters are treated for different services. |
| Establishing the relationship | What a state requires to establish a valid provider-patient relationship before prescribing via telehealth. |
| Controlled-substance limits | State-specific restrictions, prescription monitoring program checks, and documentation requirements that go beyond federal rules. |
| Patient location and licensure | Requirements tied to where the patient is physically located at the time of the visit, and licensure in that state. |
The takeaway is that “is this allowed?” almost always has a federal answer and a state answer, and both must line up. When they conflict, the stricter requirement generally governs. If you practice across state lines, you have to satisfy each state where your patients are located, not just your home state.
Practical Posture
How to Operate Responsibly While the Rules Evolve
Build Verification Into Your Workflow
Make checking the current DEA and state requirements a documented step in your telehealth prescribing process, not an afterthought. Record the date you verified and the source.
Know Where Your Patient Is
Confirm the patient’s physical location at each visit, since licensure and prescribing rules can hinge on the state the patient is in, not where you are.
Document to the Standard of Care
Strong clinical documentation supports appropriate prescribing regardless of how rules shift. Meeting the standard of care is expected of you either way.
Get Professional Guidance
For your specific situation, especially involving controlled substances across states, consult qualified healthcare counsel and your state board rather than relying on general summaries.
If you are still standing up the practice around this, telehealth is one piece of a larger setup that also includes your entity, credentialing, and billing. Our guide to starting a PMHNP practice and the 90-day launch checklist put telehealth in that broader context, PMHNP credentialing covers the enrollment side, and our PMHNP practice resources tie the pieces together.
Common Questions
Frequently Asked Questions
Can a PMHNP prescribe controlled substances via telehealth right now?
The rules for this are actively evolving, and we are not stating a firm yes-or-no here because it can change. As of this page’s review date, extended federal flexibilities exist alongside an evolving permanent framework. Confirm the current status directly with the DEA and your state board before prescribing.
Is prescribing non-controlled psychiatric medications by telehealth simpler?
Generally yes. Non-controlled medications are not governed by the DEA’s controlled-substance framework, so they are primarily subject to your state’s telehealth and scope-of-practice rules and the standard of care. You still need to verify and follow your state’s requirements.
Did the pandemic-era telehealth prescribing flexibilities expire?
As of this page’s review date, they had been extended rather than allowed to lapse, while a permanent framework was still being developed. We are not publishing a specific expiration date here because it has changed before. Check the DEA for the current effective dates.
What is the Ryan Haight Act in plain terms?
It is the 2008 federal law that, subject to exceptions, generally established an in-person evaluation requirement before prescribing controlled substances remotely. It is the baseline that the temporary flexibilities relaxed. How it applies to your situation is a legal question for qualified counsel.
Do federal rules or my state’s rules control?
Both apply, and they must line up. Federal rules set a floor; states can add stricter requirements. When they differ, the stricter one generally governs, and you must satisfy the rules of the state where the patient is located.
Where should I check for the current rules?
Start with the DEA at dea.gov for the federal picture, then your state board of nursing and state controlled-substance authority for state requirements. Re-verify periodically, since the permanent framework is still evolving.
Build It on Solid Ground
Set Up Telehealth With Compliance in Mind
The clinical value of telehealth is clear; the compliance details are what trip people up while the rules evolve. We help PMHNPs build a telehealth workflow with verification and documentation baked in, so you can focus on care. This is operational guidance, not legal advice, and we will point you to your state board and counsel where that is what you need.
Informational only, not legal, medical, billing, or tax advice. Telehealth prescribing rules, especially for controlled substances, are actively changing and vary by state; this page does not state current expiration dates or firm prescribing rules by design. Always verify the current requirements directly with the DEA (https://www.dea.gov/) and your state board of nursing and controlled-substance authority, and consult qualified counsel for your situation. Last reviewed: July 2026.